Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

GRIN2A gene mutations emerge as single-gene cause of childhood schizophrenia, anxiety, and mood disorders, potentially ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.

People with schizophrenia often take strong antipsychotics that control symptoms but frequently cause rapid weight gain, high blood sugar, and a ...

Most people being treated for mental health conditions such as anxiety or depression typically use a mix of just two ...

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 15, 2025 (HealthDay News) — Most people receiving shock therapy for mental ...

Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences has initiated a Phase 3 study titled ‘A ...